Zealand Pharma A/S
ZLDPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $32 | $26 | $37 | $46 |
| - Cash | $1 | $7 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $31 | $19 | $36 | $46 |
| Revenue | $0 | $9 | $0 | $0 |
| % Growth | -99.5% | 112,212% | -10.6% | – |
| Gross Profit | $0 | $9 | $0 | $0 |
| % Margin | 13.4% | 100% | 95% | 95.5% |
| EBITDA | -$0 | $8 | -$0 | -$0 |
| % Margin | -711.2% | 89.4% | -3,992.9% | -3,059.5% |
| Net Income | -$0 | $8 | -$0 | -$0 |
| % Margin | -127.9% | 83.3% | -4,144.1% | -3,213.7% |
| EPS Diluted | -0.9 | 105.61 | -4.75 | -4.64 |
| % Growth | -100.9% | 2,323.4% | -2.4% | – |
| Operating Cash Flow | -$0 | $9 | -$1 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $9 | -$1 | -$0 |